GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 22651 - 22700 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
6V6W Q2N0S9 Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22
6V74 P14618 Crystal Structure of Human PKM2 in Complex with L-asparagine
6V75 P14618 Crystal Structure of Human PKM2 in Complex with L-aspartate
6V76 P14618 Crystal Structure of Human PKM2 in Complex with L-valine
6V7N P38571 Crystal Structure of a human Lysosome Resident Glycoprotein, Lysosomal Acid Lipase, and its Implications in Cholesteryl Ester Storage Disease (CESD)
6V7Y P15813 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
6V7Y 6V7Y Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
6V7Y P15813 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
6V7Y 6V7Y Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
6V7Y P61769 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
6V7Z P15813 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
6V7Z 6V7Z Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
6V7Z P15813 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
6V7Z 6V7Z Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
6V7Z P61769 Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
6V80 P15813 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 6V80 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 P15813 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 6V80 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 P61769 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 K7N5M3 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 A0A0B4J240 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V80 K7N5M4 Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
6V81 P76115 The crystal structure of the outer-membrane transporter YncD Probable TonB-dependent receptor YncD
6V82 O84173 Crystal structure of tryptophan synthase from Chlamydia trachomatis D/UW-3/CX
6V82 O84172 Crystal structure of tryptophan synthase from Chlamydia trachomatis D/UW-3/CX
6V8Q P40709 Structure of an inner membrane protein required for PhoPQ regulated increases in outer membrane cardiolipin
6V8X Q2N0S6 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X Q2N0S9 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X Q6N095 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X 6V8X VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X Q6N095 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X 6V8X VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X Q6PIL8 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8X Q6PIL8 VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC01 VH, VRC01 VL
6V8Z Q2N0S6 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q2N0S7 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z P0DOX5 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z 6V8Z VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z P0DOX5 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z 6V8Z VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q6N089 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q6N089 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q8N5F4 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q8N5F4 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V8Z Q6P5S8 VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure envelope glycoprotein gp120, envelope glycoprotein gp41, VRC03 VH, 10-1074 VH, 10-1074 VL, VRC03 VL
6V9U Q9NR97 Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 14c
6VBG C6FW78 Lactose permease complex with thiodigalactoside and nanobody 9043
6VBG 6VBG Lactose permease complex with thiodigalactoside and nanobody 9043

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024